Health

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse.

Publication Date: 
11/06/2019
Susan Rogers Van Katwyk, Jeremy M. Grimshaw, Miriam Nkang & et al
PLoS Medicine
1-17
Tags:
Antibiotics, Micro Organisms, Health Policy, Health Personnel, Health Care, Infectious Diseases, Africa, China, France
Health

Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea

The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance.

Publication Date: 
04/06/2019
Jungyeon Kim, Markus Haacker, Salmaan Keshavjee & et al
BMJ Global Health
4
3
1-10
Tags:
Hepatitis, Health Care, Diagnostic Methods, South Korea, Health Policy
Health

UP mulls health policy to curb out-of-pocket costs, boost life expectancy

Based on WHO, Unicef guidelines, the draft policy with a roadmap for 2030, has been submitted to Yogi cabinet for approval

Publication Date: 
21/05/2019
Business Standard (New Delhi)
Tags:
WHO, Health Policy, UNICEF, Health
Health

Evaluation of intensified dengue control measures with interrupted time series analysis in the Panadura Medical Officer of Health division in Sri Lanka: a case study and cost-effectiveness analysis

Dengue has become a major public health problem in Sri Lanka with a considerable economic burden.

Publication Date: 
01/05/2019
Prasad Liyanage, Joacim Rocklöv, Hasitha Tissera & et al
Lancet Planetary Health
3
1-8
Tags:
Dengue, Vector Borne Diseases, Sri Lanka, South Asia, Health Care, Health Policy, Vector Control
Health

Order of the Delhi High Court regarding permission to avail “Human Embryonic Stem Cell Therapy”, 15/04/2019

Order of the Delhi High Court in the matter of Aditya Bhatia Vs Union of India & Others dated 15/04/2019 regarding permission to avail “Human Embryonic Stem Cell Therapy” being provided to the petitoner (Aditya Bhatia) by Nutech Mediworld.

Judgement Date: 
15/04/2019
Tags:
Drugs, Medical Research, India, Health Policy, High Court, Delhi
Health

Healthcare experts explore UK-India Ayushman Bharat tie-ups

Healthcare experts from India and the UK gathered for a first-of-its-kind conference in Birmingham to explore opportunities emerging after the Indian government's Ayushman Bharat initiative.

Publication Date: 
26/03/2019
Business Standard (New Delhi)
Tags:
Health Policy, Health Care, Health Insurance, United Kingdom (UK), Health
Health

'Partnership with all stakeholders key to make India TB-free by 2025'

Union Health Secretary Preeti Sudan Sunday stressed on the partnerships with all stakeholders including doctors, paramedics, frontline health workers and community partners for achieving the goal o

Publication Date: 
25/03/2019
Business Standard (New Delhi)
Tags:
Tuberculosis (TB), Infectious Diseases, Health Policy, Health
Health

Insurance companies should reach out to remote areas to increase health coverage: IRDAI

NEW DELHI: Raising concerns over low penetration of health insurance, especially in the hinterland, and high ‘out of pocket’ expenditure on health, the insurance regulator has urged private insuran

Publication Date: 
13/03/2019
Times Of India (New Delhi)
Tags:
Health Insurance, Health Policy, Health Care, Insurance Industry, Health
Health

Basic health may Rs 50,000-10 lakh cover

The Insurance Regulatory and Development Authority of India (Irdai) released draft guidelines on standardisation of individual health products.

Publication Date: 
20/02/2019
Daily News Analysis (Delhi)
Tags:
Health, Health Policy, Health Insurance, Health Care
Health

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

The revolution in hepatitis C virus (HCV) treatment through the development of direct-acting antivirals (DAAs) has generated international interest in the global elimination of the disease as a public health threat. In 2017, this led WHO to establish elimination targets for 2030.

Publication Date: 
28/01/2019
Alastair Heffernan, Graham S Cooke, Shevanthi Nayagam & et al
Lancet
1-12
Tags:
Hepatitis, Health Care, Health Policy, WHO, Statistics

Pages